Key terms
About ETON
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest ETON news
Feb 21
7:14am ET
Eton Pharmaceuticals Secures Patent for Hydrocortisone Formulation
Feb 21
6:56am ET
Eton Pharmaceuticals awarded U.S. patent for oral liquid hydrocortisone
Feb 02
8:24am ET
Eton Pharmaceuticals announces availability of Nitisinone Capsules
Feb 02
8:24am ET
Correction: Eton Pharmaceuticals announces availability of Nitisinone Capsules
Dec 11
6:30am ET
Analysts Offer Insights on Healthcare Companies: Mustang Bio (MBIO), Relay Therapeutics (RLAY) and Eton Pharmaceuticals (ETON)
No recent press releases are available for ETON
ETON Financials
Key terms
Ad Feedback
ETON Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
ETON Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range